Oxidant-antioxidant enzymes and lipid peroxidation in generalized vitiligo

Clinical and Experimental Dermatology

Volumn 29, Issue 4, 2004, Pages 406-409

  Koca, R ^a,b   Armutcu, F ^a   Altinyazar, H C ^a   Gurel A ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^b Zonguldak Karaelmas Universitesi Tip Fakultesi   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; MALONALDEHYDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ADULT; ARTICLE; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LIPID PEROXIDATION; MELANOCYTE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VITILIGO;

ADOLESCENT; ADULT; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; VITILIGO; XANTHINE OXIDASE;

EID: 3242786402     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2004.01524.x     Document Type: Article

References (28)

1. Kovacs SO. Vitiligo. J Am Acad Dermatol 1998; 38: 647-66.
2. Mosher DB, Fitzpatrick TB et al. Hypomelanoses and hypermelanoses. In: Fitzpatrick's Dermatology in General Medicine (Freedberg, IM, Eisen, AZ, Wolff, K et al., eds), 5th edn, Vol. 1. New York: McGraw-Hill, 1999: 945-1017.
3. Castanet J, Ortonne JP. Pathophysiology of vitiligo. Clin Dermatol 1997; 15: 845-51.
4. Shaffrali F, Gawkrodger D. Management of vitiligo. Clin Exp Dermatol 2000; 25: 575-9.
5. Le Poole IC, Das PK, van den Wijngaard RM et al. Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol 1993; 2: 145-53.
6. Beazley WD, Gaze D, Panske A et al. Serum selenium levels and blood glutathione peroxidase activities in vitiligo. Br J Dermatol 1999; 141: 301-3.
7. Boisseau-Garsaud AM, Garsaud P, Lejoly-Boisseau H et al. Increase in total blood antioxidant status and selenium levels in black patients with active vitiligo. Int J Dermatol 2002; 41: 640-2.
8. Jimbow K, Chen H, Park JS et al. Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Br J Dermatol 2001; 144: 55-65.
9. Maresca V, Roccella M, Roccella F et al. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol 1997; 109: 310-3.
10. Passi S, Grandinetti M, Maggio F et al. Epidermal oxidative stress in vitiligo. Pigment Cell Res 1998; 11: 81-5.
11. Picardo M, Passi S, Morrone A et al. Antioxidant status in the blood of patients with active vitiligo. Pigment Cell Res 1994; 7: 110-5.
12. Rokos H, Beazley WD, Schallreuter KU. Oxidative stress in vitiligo, photo-oxidation of pterins produces H (2) O (2) and pterin-6-carboxylic acid. Biochem Biophys Res Commun 2002; 292: 805-11.
13. Schallreuter KU, Wood JM, Berger J. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 1991; 97: 1081-5.
14. Yildirim M, Baysal V, Inaloz HS et al. The role of oxidants and antioxidants in generalized vitiligo. J Dermatol 2003; 30: 104-8.
15. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1990; 186: 421-31.
16. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
17. Prajda N, Weber G. Malignant transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas. FEBS Lett 1975; 59: 245-9.
18. Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990; 36: 1440-3.
19. Bhawan J, Bhutani LK. Keratinocyte damage in vitiligo. J Cutan Pathol 1983; 10: 207-12.
20. Moellmann G, Klein-Angerer S, Scollay DA et al. Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo. J Invest Dermatol 1982; 79: 321-30.
21. 2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Invest Dermatol Symp Proc 1999; 4: 91-6.
22. Schallreuter KU, Moore J, Wood JM et al. Epidermal H (2) O (2) accumulation alters tetrahydrobiopterin (6BH4) recycling in vitiligo: identification of a general mechanism in regulation of all 6BH4-dependent processes? J Invest Dermatol 2001; 116: 167-74.
23. Latha B, Babu M. The involvement of free radicals in burn injury: a review. Burns 2001; 27: 309-17.
24. Maccarrone M, Catani M, Iraci S et al. A survey of reactive oxyjen species and their role in dermatology. J Eur Acad Dermatol Venerol 1997; 8: 185-202.
25. Coleman JW. Nitric oxide in immunity and inflammation. Int Immunopharmacol 2001; 1: 1397-406.
26. Le Poole IC, van den Wijngaard RM, Westerhof W et al. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 1996; 148: 1219-28.
27. Ivanova K, Le Poole IC, Gerzer R et al. Effect of nitric oxide on the adhesion of human melanocytes to extracellular matrix components. J Pathol 1997; 183: 469-76.
28. Rocha IM, Guillo LA. Lipopolysaccharide and cytokines induce nitric oxide synthase and produce nitric oxide in cultured normal human melanocytes. Arch Dermatol Res 2001; 293: 245-8.